Clinical Trial Update: KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for KRX-0502 (ferric citrate) in patients with non-dialysis dependent chronic kidney disease and iron deficiency anemia; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• KRX-0502 (Ferric citrate)

Snippet

Sponsor: Keryx Biopharmaceuticals | Conditions: Chronic Kidney Diseases, Iron Deficiency Anemia | Phase 4 | Status: COMPLETED | Results posted: 2021-03-12